IL6 and COVID-19: In the present study, we investigated the distribution of copy number variations (CNVs) and genetic variants located within the coding sequences of IL6 and IL6R genes, which may be employed as prognostic and drug response (pharmacogenetic) biomarkers for COVID-19 and neuroinflammatory diseases.